| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine, University of Wisconsin, the Madison General Hospital, Madison, Wisconsin 53792; the Departments of Medicine and Obstetrics and Gynecology, University of Chicago, Chicago, Illinois 60637
Address requests for reprints to: W. E. Nolten, H4/558 Clinical Science Center, University of Wisconsin, 600 Highland Avenue, Madison, Wisconsin 53792.
Plasma concentrations of cortisol and corticosteroid-binding globulin are elevated substantially in pregnancy; only the free cortisol fraction is biologically active. Previous suggestions that plasma free cortisol increased above nongravid levels in pregnancy were difficult to reconcile with the absence of manifestations of hypercortisolism. Furthermore, any such elevation should be associated with some alteration in the regulation of cortisol secretion. Therefore, the physiology of cortisol secretion was studied by measuring plasma cortisol at 20-min intervals for 24 h. Free cortisol levels were evaluated by determining the plasma free cortisol index and the rate of urinary cortisol excretion. Circadian cortisol patterns in pregnant and nonpregnant subjects were virtually identical, but total plasma cortisol was significantly higher in pregnancy. Calculated plasma biological half-lives and production rates of cortisol were increased significantly in gravidas (t
: pregnant, 104.6 min; nonpregnant, 69.5 min; daily production rate: pregnant, 28.0 mg; nonpregnant, 11.2 mg). Such increases should produce rises in plasma free cortisol, an assumption supported by finding elevations of the free cortisol index in gravidas at 0800 and 2400 h (pregnant, 14.9 ± 1.9 and 3.3 ± 0.2; nonpregnant, 4.0 ± 0.6 and 1.2 ± 0.3) and elevations of the 24-h urinary cortisol excretion rate. Normal circadian rhythmicity despite elevated free cortisol suggests that maternal hypothalamic-pituitary regulation is altered. Resetting of feedback and lack of manifestations of hypercortisolism could be explained by tissue refractoriness to the effects of cortisol in pregnancy.
* This work was supported in part by the Madison General Hospital Endocrine Research Fund and Grants HD-5572, HL-17982, and RR-55 from the NIH.
Received November 13, 1979.
This article has been cited by other articles:
![]() |
J. R. Lindsay and L. K. Nieman The Hypothalamic-Pituitary-Adrenal Axis in Pregnancy: Challenges in Disease Detection and Treatment Endocr. Rev., October 1, 2005; 26(6): 775 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Lindsay, J. Jonklaas, E. H. Oldfield, and L. K. Nieman Cushing's Syndrome during Pregnancy: Personal Experience and Review of the Literature J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3077 - 3083. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bloch, D. R. Rubinow, P. J. Schmidt, A. Lotsikas, G. P. Chrousos, and G. Cizza Cortisol Response to Ovine Corticotropin-Releasing Hormone in a Model of Pregnancy and Parturition in Euthymic Women with and without a History of Postpartum Depression J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 695 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Crocker, N Lawson, and J Fletcher Effect of pregnancy and obstructive jaundice on inflammatory diseases: the work of P S Hench revisited Ann Rheum Dis, April 1, 2002; 61(4): 307 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Spaziani, W. F. O'Brien, R. R. Benoit, and S. F. Gould Corticotropin-Releasing Hormone Increases the Expression of the Prostaglandin E2 Receptor Subtype EP1 in Amnion WISH Cells Biol Reprod, January 1, 2000; 62(1): 23 - 26. [Abstract] [Full Text] |
||||
![]() |
C. Korebrits, M. M. Ramirez, L. Watson, E. Brinkman, A. D. Bocking, and J. R. G. Challis Maternal Corticotropin-Releasing Hormone Is Increased with Impending Preterm Birth J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1585 - 1591. [Abstract] [Full Text] |
||||
![]() |
R. Jonsson, B.E. Howland, and G.H.W. Bowden Relationships between Periodontal Health, Salivary Steroids, and Bacteroides intermedius in Males, Pregnant and Non-pregnant Women Journal of Dental Research, August 1, 1988; 67(8): 1062 - 1069. [Abstract] [PDF] |
||||
![]() |
M. I. Evans, G. P. Chrousos, D. W. Mann, J. W. Larsen Jr, I. Green, J. McCluskey, D. L. Loriaux, J. C. Fletcher, G. Koons, J. Overpeck, et al. Pharmacologic Suppression of the Fetal Adrenal Gland In Utero: Attempted Prevention of Abnormal External Genital Masculinization in Suspected Congenital Adrenal Hyperplasia JAMA, February 15, 1985; 253(7): 1015 - 1020. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |